<DOC>
	<DOCNO>NCT01710605</DOCNO>
	<brief_summary>The STIC CTC study randomize trial evaluate medico-economic interest take account circulate tumor cell ( CTC ) determine kind first line treatment metastatic , hormone-receptors positive , breast cancer . In standard arm , kind treatment decide clinician , take account criterion usually use set . In CTC arm , type treatment decide CTC count : hormone-therapy &lt; 5CTC/7.5mll ( CellSearch technique ) chemotherapy =5 . The main medical objective demonstrate non-inferiority CTC-based strategy progression-free survival : 994 patient need , accrue French cancer center . Secondary clinical objective compare toxicity , quality life overall survival two arm . The medico-economic study compare cost per progression-free life year gain two strategy . The financial impact centralize ( one platform ) v decentralize ( several platform ) CTC test evaluate .</brief_summary>
	<brief_title>Medico-economic Interest Taking Into Account Circulating Tumor Cells ( CTC ) Determine Kind First Line Treatment Metastatic , Hormone-receptors Positive , Breast Cancers</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Neoplastic Cells , Circulating</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<criteria>Women metastatic ductal adenocarcinoma breast cancer 18 year old Hormone receptor positive breast cancer ( ER+ and/or PR+ ) last pathological analysis available . Acceptable patient 's clinical situation compatible chemotherapy hormonotherapy administration PS &lt; 4 Life expectancy &gt; 3 month Evidence measurable evaluable disease ( RECIST 1.1 criterion ) 28 day selection Information patient signature inform consent form Patient treat chemotherapy hormonotherapy metastatic disease ( treatment failure adjuvant hormonotherapy accept ) Her2 positive breast cancer History stage II III cancer 5 year . History metastatic cancer ( whatever time two cancer ) . Persons deprive freedom guardianship . Women unable comply medical followup study geographical , social mental reason .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Circulating tumor cell</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Hormone-receptors positive</keyword>
</DOC>